01 1Wuhan Wuyao Pharmaceutical Co. , Ltd.
02 1Yashiro Pharmaceutical Co., Ltd.
01 2Sulpyrine hydrate
01 1China
02 1Blank
Registration Number : 229MF10033
Registrant's Address : Room No. 1-6, Floor 23, Building 1#, No. 160 Qiaokou Road Qiaokou District
Initial Date of Registration : 2017-02-08
Latest Date of Registration : 2017-02-08
Registration Number : 222MF10084
Registrant's Address : 10-2 Yoshida Shimojima, Higashiosaka City, Osaka Prefecture
Initial Date of Registration : 2010-03-16
Latest Date of Registration : 2010-03-16
A Novaminsulfon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novaminsulfon, including repackagers and relabelers. The FDA regulates Novaminsulfon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novaminsulfon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Novaminsulfon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Novaminsulfon supplier is an individual or a company that provides Novaminsulfon active pharmaceutical ingredient (API) or Novaminsulfon finished formulations upon request. The Novaminsulfon suppliers may include Novaminsulfon API manufacturers, exporters, distributors and traders.
click here to find a list of Novaminsulfon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Novaminsulfon Drug Master File in Japan (Novaminsulfon JDMF) empowers Novaminsulfon API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Novaminsulfon JDMF during the approval evaluation for pharmaceutical products. At the time of Novaminsulfon JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Novaminsulfon suppliers with JDMF on PharmaCompass.
We have 2 companies offering Novaminsulfon
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
